News | May 25, 2023
Piramal Pharma posts Q4 FY23 consolidated PAT at Rs. 50.11 Cr
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
The company has reported total income of Rs. 2188.08 crores during the period ended March 31, 2023
The company has reported total income of Rs. 3928.8 crores during the period ended March 31, 2023
The company has reported total income of Rs. 58.42 crores during the period ended March 31, 2023
Anuh Pharma has reported total income of Rs. 158.34 crores during the period ended March 31, 2023
Eris Lifesciences has reported total income of Rs. 403.80 crores during the period ended March 31, 2023
The company has reported total income of Rs. 815.11 crores during the period ended March 31, 2023
The company has reported total income of Rs. 1392.72 crores during the period ended March 31, 2023
The company has reported total income of Rs. 2971.27 crores during the period ended March 31, 2023
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
